Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV infected individuals

被引:115
作者
Anderson, PL [1 ]
Kakuda, TN [1 ]
Kawle, S [1 ]
Fletcher, CV [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Antiviral Pharmacol Lab, Denver, CO 80262 USA
关键词
adherence; antiretroviral therapy; clinical pharmacology; HIV; nucleoside analog reverse transcriptase inhibitor; pharmacodynamics; pharmacokinetics; phosphorylation; triphosphate; HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITOR THERAPY; NUCLEOSIDE-ANALOG THERAPY; BLOOD MONONUCLEAR-CELLS; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; PHOSPHORYLATION; PHARMACOLOGY; AIDS; PHARMACOKINETICS;
D O I
10.1097/00002030-200310170-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: Nucleoside analog reverse transcriptase inhibitors (NRTI) are used in virtually all anti-HIV regimens. Clinical response depends on the intracellular formation of the pharmacologically active triphosphate moiety. Our objective was to quantify the pharmacological characteristics of zidovudine and lamivudine triphosphate in HIV-infected individuals. Methods: Peripheral blood mononuclear cells were obtained at multiple planned intervals from anti retroviral-naive adults participating in a study of zidovudine, lamivudine and indinavir, and triphosphate levels were determined by immunoassay and high-performance liquid chromatography/mass spectrometry. Plasma HIV-RNA, CD4 cell counts, and plasma drug concentrations were collected over 18 months. Data were analysed using non-parametric, regression and time-to-event methods. Results: Thirty-three subjects were evaluated. The estimated half-lives of zidovudine and lamivudine triphosphate were 7 and 22 h, respectively. Triphosphate concentrations were elevated in individuals with low baseline CD4 cell counts. Triphosphate concentrations in women were higher than in men by 2.3 and 1.6-fold for zidovudine and lamivudine, respectively. Women reached an HIV-RNA level under 50 copies/ml twice as fast as men. Zidovudine triphosphate above 30 fmol/10(6) cells was independently predictive of the time to under 50 copies/ml. Lamivudine triphosphate above 7017 fmol/106 cells was independently predictive of a longer virological response. Indinavir concentrations were related to antiviral responses in univariate analyses. Conclusion: Zidovudine and lamivudine triphosphate concentration thresholds were independently associated with the antiviral activity of zidovudine, lamivudine, and indinavir. The significantly elevated triphosphate concentrations in women and individuals with low baseline CD4 cell counts, groups that historically experience high rates of serious NRTI toxicities, provide a hypothesis for the pathogenesis of these events. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:2159 / 2168
页数:10
相关论文
共 37 条
  • [11] Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons
    Fletcher, CV
    Kawle, SP
    Kakuda, TN
    Anderson, PL
    Weller, D
    Bushman, LR
    Brundage, RC
    Remmel, RP
    [J]. AIDS, 2000, 14 (14) : 2137 - 2144
  • [12] Concentration-controlled compared with conventional antiretroviral therapy for HIV infection
    Fletcher, CV
    Anderson, PL
    Kakuda, TN
    Schacker, TW
    Henry, K
    Gross, CR
    Brundage, RC
    [J]. AIDS, 2002, 16 (04) : 551 - 560
  • [13] Concentration-controlled zidovudine therapy
    Fletcher, CV
    Acosta, EP
    Henry, K
    Page, LM
    Gross, CR
    Kawle, SP
    Remmel, RP
    Erice, A
    Balfour, HH
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (03) : 331 - 338
  • [14] FORTGANG IS, 1995, AM J GASTROENTEROL, V90, P1433
  • [15] PHOSPHORYLATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND SELECTIVE INTERACTION OF THE 5'-TRIPHOSPHATE WITH HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    FURMAN, PA
    FYFE, JA
    STCLAIR, MH
    WEINHOLD, K
    RIDEOUT, JL
    FREEMAN, GA
    LEHRMAN, SN
    BOLOGNESI, DP
    BRODER, S
    MITSUYA, H
    BARRY, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) : 8333 - 8337
  • [16] Galli M, 2002, J ACQ IMMUN DEF SYND, V29, P21, DOI 10.1097/00126334-200201010-00003
  • [17] GAO WY, 1994, J BIOL CHEM, V269, P12633
  • [18] Intracellular carbovir triphosphate levels in patients taking abacavir once a day
    Harris, M
    Back, D
    Kewn, S
    Jutha, S
    Marina, R
    Montaner, JSG
    [J]. AIDS, 2002, 16 (08) : 1196 - 1197
  • [19] Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management
    Hirsch, MS
    Conway, B
    D'Aquila, RT
    Johnson, VA
    Brun-Vézinet, F
    Clotet, B
    Demeter, LM
    Hammer, SM
    Jacobsen, DM
    Kuritzkes, DR
    Loveday, C
    Mellors, JW
    Vella, S
    Richman, DD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24): : 1984 - 1991
  • [20] CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXY-2',3'-DIDEHYDROTHYMIDINE, A NUCLEOSIDE ANALOG ACTIVE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
    HO, HT
    HITCHCOCK, MJM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) : 844 - 849